Crossmark

Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison

Published Print: 2019-09

Authors

Nieto-Gómez, P.

Ubago-Pérez, R.

Cabeza-Barrera, J.
Funding

Funding for this research was provided by:

Energy Market Authority of Singapore

Health Technology Assessment Programme

Agency for Healthcare Research and Quality

Food and Drug Administration

National Institute for Health and Care Excellence
License Information

Text and Data Mining valid from 2019-09-01

Text and Data Mining valid from 2019-09-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2019.03.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2019.03.007

Content Type: article

Copyright: © 2019 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current